Stockscreener 앱 받기
72.13
0.07%
-0.05
Avidity Biosciences Inc 주식(RNA)의 최신 뉴스
Assenagon Asset Management S.A. Has $2 Million Holdings in Avidity Biosciences, Inc. $RNA - MarketBeat
How Avidity Biosciences Inc. stock valuations compare to rivalsQuarterly Market Summary & Risk Adjusted Buy/Sell Alerts - Улправда
Avidity Biosciences Earnings Notes - Trefis
Exit Recap: Is Avidity Biosciences Inc. stock resilient to inflationJuly 2025 Spike Watch & Long-Term Growth Plans - ulpravda.ru
Avidity Biosciences stock hits all-time high at 72.23 USD By Investing.com - Investing.com South Africa
Avidity Biosciences stock hits all-time high at 72.23 USD - Investing.com
Officer Calderaro III Surrenders 9,726 Of Avidity Biosciences Inc [RNA] - TradingView — Track All Markets
Officer Flanagan Surrenders 13,695 Of Avidity Biosciences Inc [RNA] - TradingView — Track All Markets
Officer Mosbrooker Surrenders 47,990 Of Avidity Biosciences Inc [RNA] - TradingView — Track All Markets
Officer Gallagher Surrenders 41,366 Of Avidity Biosciences Inc [RNA] - TradingView — Track All Markets
Officer McCarthy Acquires 21,702 Of Avidity Biosciences Inc [RNA] - TradingView — Track All Markets
Avidity Biosciences (NASDAQ:RNA) Lowered to Hold Rating by Evercore ISI - MarketBeat
Will Avidity Biosciences Inc. stock gain from strong economy2025 Institutional Moves & Technical Buy Zone Confirmation - DonanımHaber
RNA SEC FilingsAvidity Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Avidity Biosciences receives FTC clearance for Novartis merger - MSN
Avidity reports FTC granted request for early termination of HSR waiting period - MSN
Novartis-Avidity Biosciences deal gets early clearance in US - MLex
Evercore ISI Downgrades Avidity Biosciences to In Line From Outperform, Adjusts Price Target to $72 From $65 - marketscreener.com
Avidity Biosciences Receives FTC Clearance for Novartis Merger - TipRanks
Avidity Biosciences (NASDAQ:RNA) Sets New 52-Week HighHere's Why - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Is Avidity Biosciences Inc. stock resilient to inflation2025 Key Highlights & Real-Time Price Movement Reports - Bollywood Helpline
Mirador Capital Partners LP Purchases 22,666 Shares of Avidity Biosciences, Inc. $RNA - MarketBeat
Avidity Biosciences (NASDAQ: RNA) advances Novartis merger and revises executive pay - Stock Titan
Top 2 Health Care Stocks That May Keep You Up At Night In December - Benzinga
Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity - MSN
Frazier Life Sciences Management L.P. Has $17.75 Million Stock Holdings in Avidity Biosciences, Inc. $RNA - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Reaches New 52-Week HighWhat's Next? - MarketBeat
EcoR1 Capital LLC Sells 57,576 Shares of Avidity Biosciences, Inc. $RNA - MarketBeat
Avidity Biosciences stock hits all-time high at 71.81 USD By Investing.com - Investing.com Australia
Avidity Biosciences stock hits all-time high at 71.81 USD - Investing.com
Aug Closing: Is Avidity Biosciences Inc stock vulnerable to regulatory risksTrade Performance Summary & Growth-Oriented Investment Plans - moha.gov.vn
Avoiding Lag: Real-Time Signals in (RNA) Movement - news.stocktradersdaily.com
Avidity Biosciences (RNA) Soars 42% on $12-Billion Novartis Merger - MSN
Assessing Avidity Biosciences (RNA) Valuation After a 130% Year-to-Date Share Price Surge - Yahoo Finance
Dyne stock upgraded at Oppenheimer (DYN:NASDAQ) - Seeking Alpha
Dyne Therapeutics' Biggest Catalyst is Avidity Biosciences' DM1 Readout in H2 2026, Oppenheimer Says - marketscreener.com
Norges Bank Makes New Investment in Avidity Biosciences, Inc. $RNA - MarketBeat
Franklin Resources Inc. Sells 29,465 Shares of Avidity Biosciences, Inc. $RNA - MarketBeat
JPMorgan Chase & Co. Buys 139,473 Shares of Avidity Biosciences, Inc. $RNA - MarketBeat
Avidity Biosciences stock hits all-time high at 71.78 USD By Investing.com - Investing.com South Africa
Avidity Biosciences stock hits all-time high at 71.78 USD - Investing.com
Why Avidity Biosciences Inc. stock could benefit from AI revolution2025 Breakouts & Breakdowns & Free Expert Approved Momentum Trade Ideas - Newser
Avidity Biosciences, Inc. (RNA): A Bull Case Theory - Finviz
Schroder Investment Management Group Raises Stake in Avidity Biosciences, Inc. $RNA - MarketBeat
How Avidity Biosciences Inc. stock reacts to Fed rate cutsEarnings Overview Summary & AI Enhanced Trade Execution Alerts - Newser
Avidity Biosciences, Inc. $RNA Shares Sold by Steward Partners Investment Advisory LLC - MarketBeat
Avidity Biosciences, Inc. $RNA Shares Sold by Prudential Financial Inc. - MarketBeat
Will Avidity Biosciences Inc. stock outperform Dow Jones indexMarket Growth Report & Detailed Earnings Play Alerts - Newser
Creative Planning Grows Stock Holdings in Avidity Biosciences, Inc. $RNA - MarketBeat
0.08%
0.21%
자본화:
|
볼륨(24시간):